# Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis

> **NCT03419429** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 40 (actual)

## Conditions studied

- Chronic Periodontitis

## Interventions

- **DRUG:** Simvastatin
- **OTHER:** EDTA
- **DEVICE:** Occlusive membrane
- **DEVICE:** Modified perforated membrane

## Key facts

- **NCT ID:** NCT03419429
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419429, "Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03419429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*